RT Journal Article
T1 SEOM-TTCC clinical guideline in nasopharynx cancer (2021).
A1 Rueda Domínguez, Antonio
A1 Cirauqui, Beatriz
A1 García Castaño, Almudena
A1 Alvarez Cabellos, Ruth
A1 Carral Maseda, Alberto
A1 Castelo Fernández, Beatriz
A1 Iglesias Rey, Leticia
A1 Rubió-Casadevall, Jordi
A1 Arrazubi, Virginia
A1 Mesía, Ricard
K1 Clinical Practice Guidelines
K1 Diagnosis
K1 Follow-up
K1 Nasopharyngeal cancer
K1 Treatment
AB Nasopharyngeal carcinoma (NPC) is distinct from other cancers of the head and neck in biology, epidemiology, histology, natural history, and response to treatment. Radiotherapy (RT) is the cornerstone of locoregional treatment of non-disseminated disease and the association of chemotherapy improves the rates of survival. In the case of metastatic disease stages, treatment requires platinum/gemcitabine-based chemotherapy and patients may achieve a long survival time.
YR 2022
FD 2022-03-18
LK http://hdl.handle.net/10668/21108
UL http://hdl.handle.net/10668/21108
LA en
DS RISalud
RD Apr 11, 2025